Cubist Systematic Strategies, LLC Simulations Plus, Inc. Transaction History

Cubist Systematic Strategies, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$40.03 - $51.51 $525,794 - $676,583	-13,135 Reduced 53.12%	11,594 $483,000
Q2 2023 Aug 14, 2023	BUY	$40.45 - $48.0 $1 Million - $1.19 Million	24,729 New	24,729 $1.07 Million
Q4 2022 Feb 14, 2023	BUY	$36.55 - $51.15 $103,692 - $145,112	2,837 Added 11.47%	27,566 $1.01 Million
Q3 2022 Nov 14, 2022	SELL	$47.75 - $66.88 $693,473 - $971,298	-14,523 Reduced 37.0%	24,729 $1.2 Million
Q2 2022 Aug 15, 2022	BUY	$40.55 - $51.76 $1.59 Million - $2.03 Million	39,252 New	39,252 $1.94 Million
Q2 2021 Aug 16, 2021	SELL	$49.67 - $68.96 $207,819 - $288,528	-4,184 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$60.06 - $89.52 $62,702 - $93,458	1,044 Added 33.25%	4,184 $265,000
Q4 2020 Feb 16, 2021	BUY	$53.26 - $77.18 $167,236 - $242,345	3,140 New	3,140 $226,000
Q1 2020 May 15, 2020	SELL	$26.79 - $38.99 $251,236 - $365,648	-9,378 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$29.07 - $35.63 $65,901 - $80,773	2,267 Added 31.88%	9,378 $273,000
Q3 2019 Nov 14, 2019	BUY	$28.19 - $41.75 $200,459 - $296,884	7,111 New	7,111 $247,000

176

15.2M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $636M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.